SaúdeTexto original em inglês
FDA approves weekly Mimrylo injection for rare blood cancer
Protagonist developed the drug, which Takeda will sell under the Mimrylo brand.
Redigido por IA2 fontes1 min
Loading…
Diagnósticos, próteses, vacinas, genómica: a medicina que ganha anos de vida.
A medicina que ganha anos de vida: rastreios assistidos por IA que examinam milhões de doentes, vacinas de nova geração, uma genómica que passa da sequenciação ao tratamento, próteses e implantes que devolvem capacidades perdidas. A secção segue os ensaios clínicos concluídos, as autorizações de introdução no mercado, as implantações hospitalares — o momento em que uma tecnologia deixa de ser uma publicação para se tornar um cuidado.
Os números mandam: coortes, taxas de deteção, mortalidade evitada, custos. Cobrimos de bom grado os sistemas de saúde que implantam em grande escala — a Índia, o Brasil, o Sudeste Asiático — porque as tecnologias frugais costumam provar-se aí antes de chegarem a outros lugares. Cada artigo apoia-se no ensaio, na autorização ou no estudo que o funda, e cita-os.
Protagonist developed the drug, which Takeda will sell under the Mimrylo brand.
UC Berkeley researchers compared eight Myotis genomes and found a link between longer life spans and cancer-fighting genes.
The 10-year STAREE trial followed nearly 10,000 independently living older adults in Australia.
A trial of 2,501 men found specialist referrals increased statin and blood-pressure treatment.
Danish registers followed 132,585 people diagnosed with type 2 diabetes from 2006 through 2019.
An exploratory analysis found a more favorable long-term quality-of-life trajectory with twice-daily radiation.
The 68 Ga/177 Lu-NYM096 pair uses one compound to image tumors and deliver targeted radiation.
Pacibekitug kept inflammation markers down through day 180 in adults with kidney disease and elevated inflammatory risk associated with heart disease.
TARGET-CTCA randomly assigned 3,170 people across 14 UK emergency departments.
MD Anderson researchers linked BRAF to the development and persistence of pain after nerve injury.
TU Wien researchers implanted cell-loaded DEGRAD INX scaffolds in a rabbit knee defect.
Abbott’s Libre Duo 10 Day reads ketones and glucose every minute for 10 days.
The open-label trial randomized 1,803 people at 18 South Korean centers to DOACs or no anticoagulation.
The University of Virginia team found 69.8% of patients had metastatic disease, including aggressive cancers such as pancreatic cancer.
The randomized trial enrolled 12 adults with drug-resistant epilepsy in Taiwan.
Boston University researchers identified lung-vein cells that become active after injury and promote scar formation.
The study covered 805 adults who received living-donor kidney transplants in Japan between 2001 and 2021.
Screening found HCV in 4.1% of people in custody, versus 0.3% in Hong Kong's general population.